Generic Name and Formulations:
Rimexolone 1%; oph susp; contains benzalkonium chloride.
Alcon Laboratories, Inc.
Indications for VEXOL:
Post-op inflammation. Anterior uveitis.
Post-op: 1–2 drops into conjunctival sac(s) 4 times daily; start 24 hrs after surgery and continue through 1st 2 weeks post-op. Uveitis: 1–2 drops into the conjunctival sac(s) every hour while awake for 1st week, then 1 drop every 2 hrs while awake for 2nd week, then taper until resolved.
Epithelial herpes simplex keratitis and other viral infections including vaccinia, varicella. Ocular mycobacterial, fungal, or untreated purulent infections.
Corneal or scleral thinning. Monitor intraocular pressure. Pregnancy (Cat.C). Nursing mothers: not recommended.
Blurred vision, discharge, discomfort, ocular pain, increased intraocular pressure, foreign body sensation, hyperemia, pruritus; may mask secondary ocular infections; ocular hypertension/glaucoma, optic nerve damage, defects in visual acuity and visual fields, posterior subcapsular cataract formation, superinfection possible with prolonged use.